Abiopharma

Appendix 3Y for Gregory George

Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Burning Rock Announces Results of 2025 Annual General Meeting

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

ResMed Inc. Daily Stock Update

Celularity Announces Closing of Financing Transactions

Where To Buy and What To Look For When Buying An Xbox Series X

インサイト・ジャパン、進行肛門がんの一次治療としてジニイズ（Zynyz）®（レチファンリマブ）の承認を発表

M2 vs M3 Chip: Performance Comparison in 2026

How to Use WhatsApp (2026 Guide)